AIG
SLXP

American International Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

American International Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-127,895
Closed -$22.1M – 5321
2015
Q1 		$22.1M Buy
127,895
+3,705
+3% +$544K 0.09% 122
2014
Q4 		$14.3M Sell
124,190
-3,070
-2% -$372K 0.06% 206
2014
Q3 		$19.9M Buy
127,260
+657
+0.5% +$95.2K 0.09% 128
2014
Q2 		$15.6M Sell
126,603
-3,936
-3% -$435K 0.07% 173
2014
Q1 		$13.5M Buy
130,539
+1,261
+1% +$129K 0.06% 202
2013
Q4 		$11.6M Sell
129,278
-1,644
-1% -$131K 0.06% 240
2013
Q3 		$8.76M Buy
130,922
+124,210
+1,851% +$8.56M 0.05% 350
2013
Q2 		$444K Buy
+6,712
New +$384K ﹤0.01% 1943

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

American International Group's SLXP Position: Q2 2015 in Review

American International Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 127,895 shares — an estimated $22.1M sold.

American International Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $22.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • American International Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • American International Group sold 127,895 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $22.1M.
  • American International Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • American International Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $22.1M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on American International Group's 13F filing for Q2 2015, filed 12 Aug 2015.